Truist Financial Corp Argenx Se Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Argenx Se stock. As of the latest transaction made, Truist Financial Corp holds 4,011 shares of ARGX stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,011

Previous 3,640 10.19%

Holding current value

$2.26 Million

Previous $1.57 Million 38.98%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$434.22 - $551.9 $161,095 - $204,754	371 Added 10.19%	4,011 $2.18 Million
Q2 2024 Aug 20, 2024	SELL	$356.01 - $451.55 $54,825 - $69,538	-154 Reduced 4.06%	3,640 $1.57 Million
Q1 2024 May 10, 2024	BUY	$356.95 - $413.29 $46,046 - $53,314	129 Added 3.52%	3,794 $1.49 Million
Q4 2023 Feb 02, 2024	SELL	$338.91 - $506.01 $252,826 - $377,483	-746 Reduced 16.91%	3,665 $1.39 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $849,135 - $1.26 Million	2,299 Added 108.85%	4,411 $2.17 Million
Q2 2023 Aug 01, 2023	BUY	$360.14 - $422.58 $224,007 - $262,844	622 Added 41.74%	2,112 $823,000
Q1 2023 May 05, 2023	BUY	$334.23 - $403.65 $53,142 - $64,180	159 Added 11.95%	1,490 $555,000
Q4 2022 Feb 17, 2023	BUY	$342.17 - $402.31 $59,195 - $69,599	173 Added 14.94%	1,331 $504,000
Q3 2022 Oct 26, 2022	BUY	$343.2 - $395.75 $173,316 - $199,853	505 Added 77.34%	1,158 $409,000
Q2 2022 Jul 22, 2022	BUY	$269.58 - $378.88 $176,035 - $247,408	653 New	653 $247,000
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $578,497 - $719,820	-2,250 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $41,586 - $58,948	155 Added 7.4%	2,250 $620,000
Q4 2020 Feb 18, 2021	BUY	$248.13 - $308.36 $15,632 - $19,426	63 Added 3.1%	2,095 $616,000
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $2,801 - $3,542	13 Added 0.64%	2,032 $534,000
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $22,684 - $41,424	178 Added 9.67%	2,019 $454,000
Q1 2020 May 15, 2020	SELL	$108.83 - $165.23 $4,244 - $6,443	-39 Reduced 2.07%	1,841 $242,000
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $200,389 - $308,714	1,880 New	1,880 $302,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Argenx Se Transaction History